One Lot of Xembify Withdrawn
January 17, 2025
On Jan. 13, 2025, Grifols Therapeutics LLC withdrew one lot to the consumer level for Xembify® (immune globulin subcutaneous, human-klhw) 20% 4G vial
Orders may be delayed due to Winter Weather.
After notification of any recall, Express Scripts will continue processing new and refill prescriptions with product from non-recalled lots or manufacturers, if available. Please visit the U.S. Food and Drug Administration (FDA) website for the most up-to-date information on drug safety and recalls.
The information on this site is not intended to take the place of your doctor or other healthcare professionals. It is a resource to help you make the best decisions and get the most from the medical services available to you. A licensed physician should be consulted for diagnosis and treatment of all medical conditions.